Delivery Order SPE2DR25D2018-SPE2DR26FZ2Q2
Award Date 4/29/26
Potential Completion Date 4/30/26
Potential Value $20K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $11,770 delivery order to Amerisourcebergen Drug Corp on April 28, 2026, for NURTEC ODT 75 mg tablets (8-count units), with ultimate completion by April 29, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to federal...
- The Defense Logistics Agency issued a $14,211.64 delivery order to Amerisourcebergen Drug Corp on April 24, 2026, for NURTEC ODT 75 MG tablets (8-count packaging), with an ultimate completion date of April 27, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed-price under a no-set-aside full-and-open competitive award. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., operating as a prime contractor on the...
- The Defense Logistics Agency issued a $13,710.38 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for NURTEC ODT 75 mg tablets (8-count units), with an ultimate completion date of April 24, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and subsidiary of Cencora, Inc., competing on full-and-open competitive awards. The company holds a single-award...
- The Defense Logistics Agency issued a $9,349.56 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for NURTEC ODT 75 MG tablets (8-count), with an ultimate completion date of April 7, 2026. Place of performance is Conshohocken, PA. The order is priced firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and is a major pharmaceutical distributor supplying federal medical procurement needs through the Defense Logistics...
- The Defense Logistics Agency issued a $19,914.96 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for NURTEC ODT 75 mg tablets (8-count packaging), with a completion date of April 30, 2026. Place of performance is Conshohocken, Pennsylvania. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical...
- The Defense Logistics Agency issued a $3,186.12 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for NURTEC ODT 75 mg tablets (8-tablet packs), with an ultimate completion date of April 28, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical...
- <p>The Defense Logistics Agency issued a $24,932.06 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for NURTEC ODT 75 mg tablets (8-count packaging), with an ultimate completion date of April 21, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems.</p>
- The Defense Logistics Agency issued a $8,329.57 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for NURTEC ODT 75 MG Tablet 8s, with ultimate completion on April 23, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on full-and-open competitive awards to the Defense Logistics Agency and federal healthcare...
- The Defense Logistics Agency issued a $16,681.35 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for NURTEC ODT 75 MG tablets (8-count). Place of performance is Conshohocken, PA. Ultimate completion date is April 20, 2026. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to the...
- The Defense Logistics Agency issued a $28,978.27 delivery order to Amerisourcebergen Drug Corp on April 28, 2026, for NURTEC ODT 75 MG tablets (8-count packages), with an ultimate completion date of April 29, 2026. The order is firm fixed-price with no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen operates as a pharmaceutical distributor and medical supplier serving Department of Defense and federal healthcare systems. The company holds a single-award indefinite delivery...
- SPE2DR25D2018Indefinite Delivery Contract
- SPE2DR25D2018-SPE2DR26FZ2Q2Delivery Order
The Defense Logistics Agency issued a $19,955.61 delivery order to AmerisourceBergen Drug Corp on April 29, 2026, for NURTEC ODT 75 MG tablets (8-count units), with ultimate completion by April 30, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications to federal healthcare systems. The company holds a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 7/28/26, 10:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 4/28/26 |